🇺🇸 FDA
Patent

US 6395745

Alkaloid halide salts of swainsonine and methods of use

expired A61KA61K31/437

Quick answer

US patent 6395745 (Alkaloid halide salts of swainsonine and methods of use) held by GlycoDesign Holdings Ltd. expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
GlycoDesign Holdings Ltd.
Grant date
Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/437